Healthcare Sales & Marketing Network News: Squalamine

Searching News Database: Squalamine

HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 22 May 2013
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 3 Oct 2007
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Apr 2007
Genaera Corporation Names New Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 16 Oct 2006
Genaera Presents New EVIZON(TM) Safety Data at the Angiogenesis Foundation 4th Annual International Conference
Biopharmacetuicals Ophthalmology

Return to NewsFeed

Additional items found! 35

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 35 additional stories matching:
Squalamine
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.